← Open Payments lookup

SHARON HILL: Open Payments

NPI 1578701603 · PASADENA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$516 in 22 payments from 13 companies in 2025. Trend: 2023 $39 · 2024 $253 · 2025 $516

Food & beverage: $516
CompanyPaymentsAmount
Dexcom, Inc.2$115
ABBVIE INC.2$57
Boehringer Ingelheim Pharmaceuticals, Inc.3$51
Bayer Healthcare Pharmaceuticals Inc.2$47
Astellas Pharma US Inc2$40
PFIZER INC.2$39
Sumitomo Pharma America, Inc.2$37
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$37
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
Novo Nordisk Inc1$21

Products named: DEXCOM G7 GSS (161), VRAYLAR, JARDIANCE, Kerendia, Veozah, GEMTESA, XIFAXAN, CAPLYTA.

Industry payments across MD — which companies pay providers there.